Management and prevention of pertussis infection in neonates

References

• De Greeff SC, de Melker HE, Westerhof A, et al. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology 2012;23:852-60
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper. Geneva 2010. Available from: http://www.who.int/entity/wer/2010/wer8540.pdf [Last accessed on 19 August 2014]
   Google Scholar
• Berti E, Chiappini E, Orlandini E, et al. Pertussis is still common in a highly vaccinated infant population. Acta Paediatr 2014;103:846-9
   Google Scholar
• Chiappini E, Stival A, Galli L, et al. Pertussis re-emergence in the post-vaccination era. BMC Infect Dis 2013;13:151
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Pertussis epidemic – Washington. MMWR 2012;61:517-22
   PubMedGoogle Scholar
• European Centre for Disease Prevention and Control (ECDC). Vaccination schedules. Available from: http://ecdc.europa.eu/en/activities/surveillance/euvac/schedules [Last accessed on 19 August 2014]
   Google Scholar
• American Academy of Pediatrics. Pertussis (Whooping Cough). Red Book: 2012 Report of the Committee on Infectious Diseases. American Academy of Pediatrics, Elk Grove Village, IL; 2012. p. 553-66. Available from: http://aapredbook.aappublications.org/ [Last accessed on 19 August 2014]
   Google Scholar
• Long SS, Edwards KM, Mertsola J. Bordetella pertussis (Pertussis) and Other Bordetella Species. Principles and Practice of Pediatric Infectious Diseases. 4th edition. Churchill Livingstone, Philadelphia; 2012; p. 865-73
   Google Scholar
• Meine Jansen C, Miedema C. Edema as a new predominant symptom of Bordetella pertussis infection in a newborn. Eur J Pediatr 2009;168:1543-5
   PubMed Web of Science ®Google Scholar
• Heininger U, Kleemann WJ, Cherry JD; Sudden Infant Death Syndrome Study Group. A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants. Pediatrics 2004;114:9-15
   PubMed Web of Science ®Google Scholar
• Cherry JD, Paddock CD, Greer PW, et al. The respiratory pathology in infants with sudden unexpected deaths in whom respiratory specimens were initially PCR-positive or PCR-negative for Bordetella pertussis. Infection 2011;39:545-8
   PubMed Web of Science ®Google Scholar
• Faulkner A, Skoff T, Martin S, et al. Pertussis. Manual for the Surveillance of Vaccine-Preventable Diseases. 5th edition. 2011. Available from: http://www.cdc.gov/vaccines/pubs/surv-manual/chpt10-pertussis.html [Last accessed on 19 August 2014]
   Google Scholar
• Centers for Diseases Control and Prevention. Pertussis (Whooping cough). Available from: http://www.cdc.gov/pertussis/index.html [Last accessed on 19 August 2014]
   Google Scholar
• Centers for Diseases Control and Prevention (CDC). Pertussis. The Pink Book. 12th Edition Second Printing. 2012. Available from: http://www.cdc.gov/vaccines/pubs/pinkbook/downloads/pert.pdf [Last accessed on 19 August 2014]
   Google Scholar
• Cherry JD, Harrison R, Bradley JS, et al. American Academy of Pediatrics. Pertussis in Young Infants. Available from: http://www.aap-ca.org/clinical/pertussis/pertussis_in_young_infants.html [Last accessed on 19 August 2014]
   Google Scholar
• Fry NK, Duncan J, Wagner K, et al. Role of PCR in the diagnosis of pertussis infection in infants: 5 years’ experience of provision of a same-day real-time PCR service in England and Wales from 2002 to 2007. J Med Microbiol 2009;58:1023-9
   PubMed Web of Science ®Google Scholar
• Centers for Diseases Control and Prevention. Best Practices for Health Care Professionals on the use of Polymerase Chain Reaction (PCR) for Diagnosing Pertussis. Available from: http://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-pcr-bestpractices.html [Last accessed on 19 August 2014]
   Google Scholar
• Guiso N, Liese J, Plotkin S. The global pertussis initiative meeting report from the fourth regional roundtable meeting, France, April 14–15, 2010. Hum Vaccin 2011;7:481-8
   PubMedGoogle Scholar
• Bidet P, Liguori S, De Lauzanne A, et al. Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis. J Clin Microbiol 2008;46:3636-8
   PubMed Web of Science ®Google Scholar
• Dalby T, Fry NK, Krogfelt KA, et al. Evaluation of PCR methods for the diagnosis of pertussis by the European surveillance network for vaccine-preventable diseases (EUVAC.NET). Eur J Clin Microbiol Infect Dis 2013;32:1285-9
   PubMed Web of Science ®Google Scholar
• Vaz-de-Lima LR, Martin MD, Pawloski LC, et al. Clinical and Epidemiological Team Work of Hospital Sentinels of the City of São Paulo. Serodiagnosis as adjunct assay for pertussis infection in São Paulo. Brazil Clin Vaccine Immunol 2014;21:636-40
   PubMed Web of Science ®Google Scholar
• Maltezou HC, Ftika L, Theodoridou M. Nosocomial pertussis in neonatal units. J Hosp Infect 2013;85:243-8
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. Atlanta: CDC; 2007. Available from: http://www.cdc.gov/hicpac/pdf/isolation/isolation2007.pdf [Last accessed on 19 August 2014]
   Google Scholar
• Health Protection Agency. Guideline for the public health management of pertussis incidences in health-care settings. London: HPA; 2012. Available from: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317136713302 [Last accessed on 19 August 2014]
   Google Scholar
• Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001;139:380-4
   PubMed Web of Science ®Google Scholar
• Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J 2007;26:186-8
   PubMed Web of Science ®Google Scholar
• Wang Z, Li Y, Hou T, et al. Appearance of macrolide-resistant Bordetella pertussis strains in China. Antimicrob Agents Chemother 2013;57:5193-4
   PubMed Web of Science ®Google Scholar
• Guillot S, Descours G, Gillet Y, et al. Macrolide-resistant Bordetella pertussis infection in newborn girl. France. Emerg Infect Dis 2012;18:966-8
   PubMed Web of Science ®Google Scholar
• Bartkus JM, Juni BA, Ehresmann K, et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol 2003;41:1167-72
   PubMed Web of Science ®Google Scholar
• Theilen U, Johnston ED, Robinson PA. Rapidly fatal invasive pertussis in young infants–how can we change the outcome? BMJ 2008;337:343
   Google Scholar
• Kuperman A, Hoffmann Y, Glikman D, et al. Severe pertussis and hyperleukocytosis: is it time to change for exchange? Transfusion 2014;54:1630-3
   PubMed Web of Science ®Google Scholar
• Berger JT, Carcillo JA, Shanley TP, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN). Critical pertussis illness in children: a multicenter prospective cohort study. Pediatr Crit Care Med 2013;14:356-65
   PubMed Web of Science ®Google Scholar
• Kaltsas A, Sepkowitz K. Vaccinations for healthcare personnel: update on influenza, hepatitis B, and pertussis. Curr Opin Infect Dis 2013;26:366-77
   PubMedGoogle Scholar
• Kretsinger K, Broder KR, Cortese MM, et al. Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices; Healthcare Infection Control Practices Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Available from: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5517a1.htm [Last accessed on 19 August 2014]
   Google Scholar
• Maltezou HC, Wicker S, Borg M, et al. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine 2011;29:9557-62
   PubMed Web of Science ®Google Scholar
• Greer AL, Fisman DN. Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2009;30:1084-9
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Adult vaccination coverage – United States, 2010. Available from: www.cdc.gov/mmwr/preview/mmwrhtml/mm6104a2.htm [Last accessed on 19 August 2014]
   Google Scholar
• Paterson JM, Sheppeard V. Nosocomial pertussis infection of infants: still risk in 2009. Commun Dis Intell Q Rep 2010;34:440-3
   PubMedGoogle Scholar
• Rivero-Santana A, Cuéllar-Pompa L, Sánchez-Gómez LM, et al. Effectiveness and cost-effectiveness of different immunization strategies against whooping cough to reduce child morbidity and mortality. Health Policy 2014;115:82-91
   PubMed Web of Science ®Google Scholar
• Wiley KE, Zuo Y, Macartney KK, et al. Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy. Vaccine 2013;31:618-25
   PubMed Web of Science ®Google Scholar
• EUVAC-NET. Pertussis vaccination overview in European countries. Available from: http://www.euvac.net/graphics/euvac/vaccination/pertussis.html [Last accessed on 19 August 2014]
   Google Scholar
• World Health Organization. Immunization summary. A statistical reference containing data through 2012. The 2014 edition. Available from: http://www.childinfo.org/files/immunization_summary_2012_en.pdf [Last accessed on 19 August 2014]
   Google Scholar
• Indian Academy of Pediatrics, Advisory Committee on Vaccines and Immunization Practices (acvip). Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years, India, 2013 and updates on immunization. Indian Pediatr 2013;50:1095-108
   PubMed Web of Science ®Google Scholar
• Elumogo TN, Booth D, Enoch DA, et al. Bordetella pertussis in a neonatal intensive care unit: identification of the mother as the likely source. J Hosp Infect 2012;82:133-5
   Google Scholar
• van Hoek AJ, Andrews N, Campbell H, et al. The social life of infants in the context of infectious disease transmission; social contacts and mixing patterns of the very young. PLoS ONE 2013;8:e76180
   Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women–Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2013;62:131-5
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG committee opinion no. 558. Integrating immunizations into practice. Obstet Gynecol 2013;121:897-903
   PubMedGoogle Scholar
• Government of Western Australia, Department of Public Health. Pertussis (whooping cough). Available from: http://www.public.health.wa.gov.au/2/274/2/pertussis_whooping_cough_fact_sheets.pm [Last accessed on19 August 2014]
   Google Scholar
• Public Health Agency of Canada. Pertussis Prevention. Available from: http://www.phac-aspc.gc.ca/im/vpd-mev/pertussis/prevention-eng.php [Last accessed on19 August 2014]
   Google Scholar
• World Health Organization. Meeting of the Strategic Advisory Group of Experts on immunization, April 2014 – conclusions and recommendations. Wkly Epidemiol Rec 2014.89:221-36. Available from: http://www.who.int/wer/2014/wer8921.pdf [Last accessed on 19 August 2014]
   Google Scholar
• Castagnini LA, Healy CM, Rench MA, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis 2012;54:78-84
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis 2011;52:157-62
   PubMedGoogle Scholar
• Simonetti A, Martini I, Bonomo G, et al. Improving adherence rates to a cocooning program: a pilot experience in Italy. Hum Vaccin Immunother 2013;9:1142-5
   PubMedGoogle Scholar
• Urwyler P, Heininger U. Protecting newborns from pertussis - the challenge of complete cocooning. BMC Infect Dis 2014;14:397
   PubMed Web of Science ®Google Scholar
• Frère J, De Wals P, Ovetchkine P, et al. Evaluation of several approaches to immunize parents of neonates against B. pertussis. Vaccine 2013;31:6087-91
   PubMed Web of Science ®Google Scholar
• Donnan EJ, Fielding JE, Rowe SL, et al. A cross sectional survey of attitudes, awareness and uptake of the parental pertussis booster vaccine as part of a cocooning strategy, Victoria, Australia. BMC Public Health 2013;13:676
   PubMed Web of Science ®Google Scholar
• Steiner B, Swamy GK, Walter EB. Engaging expectant parents to receive Tdap vaccination. Am J Perinatol 2014;31:407-12
   PubMed Web of Science ®Google Scholar
• Beel ER, Rench MA, Montesinos DP, et al. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother 2013;9:1926-31
   PubMed Web of Science ®Google Scholar
• Rossmann Beel E, Rench MA, Montesinos DP, et al. Acceptability of immunization in adult contacts of infants: possibility of expanding platforms to increase adult vaccine uptake. Vaccine 2014;32:2540-5
   PubMed Web of Science ®Google Scholar
• Wiley KE, Massey PD, Cooper SC. Pregnant women’s intention to take up a post-partum pertussis vaccine, and their willingness to take up the vaccine while pregnant: a cross sectional survey. Vaccine 2013;31:3972-8
   PubMed Web of Science ®Google Scholar
• Mills B, Fensterheim L, Taitel M, et al. Pharmacist-led Tdap vaccination of close contacts of neonates in a women’s hospital. Vaccine 2014;32:521-5
   PubMed Web of Science ®Google Scholar
• Guzman-Cottrill JA, Phillipi CA, Dolan SA, et al. Free vaccine programs to cocoon high-risk infants and children against influenza and pertussis. Am J Infect Control 2012;40:872-6
   PubMed Web of Science ®Google Scholar
• Rust C. A cocooning project to protect newborns from pertussis. Nurs Womens Health 2014;18:204-11
   PubMedGoogle Scholar
• Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics 2008;122:e550-5
   PubMed Web of Science ®Google Scholar
• Healy CM, Rench MA, Wootton SH, et al. Evaluation of the Impact of a Pertussis Cocooning Program on Infant Pertussis Infection. Pediatr Infect Dis J 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Quinn HE, Snelling TL, Habig A, et al. Parental dtap boosters and infant pertussis: a case control study. Pediatrics 2014;134:713-20
   PubMed Web of Science ®Google Scholar
• Cantey JB, Sánchez PJ, Tran J, et al. Pertussis: a persistent cause of morbidity and mortality in young infants. J Pediatr 2014;164:1489-92
   PubMed Web of Science ®Google Scholar
• Halperin BA, Morris A, MacKinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine (Tdap) in women of childbearing age and post-partum women. Clin Infect Dis 2011;53:885-92
   PubMed Web of Science ®Google Scholar
• Munoz F, Englund J. Infant pertussis: is cocooning the answer? Clin Infect Dis 2011;53:893-6
   Google Scholar
• Peters TR, Banks GC, Snively BM, et al. Potential impact of parental Tdap immunization on infant pertussis hospitalizations. Vaccine 2012;30:5527-32
   PubMed Web of Science ®Google Scholar
• Coudeville L, Van Rie A, Getsios D, et al. Adult vaccination strategies for the control of pertussis in the United States: an economic evaluation including the dynamic population effects. PLoS One 2009;4:e6284
   PubMed Web of Science ®Google Scholar
• Westra TA, de Vries R, Tamminga JJ, et al. Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands. Clin Ther 2010;32:1479-95
   PubMed Web of Science ®Google Scholar
• Lugnér AK, van der Maas N, van Boven M, et al. Cost-effectiveness of targeted vaccination to protect new-borns against pertussis: comparing neonatal, maternal, and cocooning vaccination strategies. Vaccine 2013;31(46):5392-7
   PubMed Web of Science ®Google Scholar
• Levy-Bruhl D. Protecting the very young against pertussis–cough, costs and cocooning. Euro Surveill 2014;19:pii. 20689
   Google Scholar
• Lim GH, Deeks SL, Crowcroft NS. A cocoon immunisation strategy against pertussis for infants: does it make sense for Ontario? Euro Surveill 2014;19; pii. 20688
   PubMedGoogle Scholar
• Skowronski DM, Janjua NZ, Tsafack ES, et al. The number needed to vaccinate to prevent infant pertussis hospitalization and death through parent cocoon immunization. Clin Infect Dis 2012;54:318-27
   PubMed Web of Science ®Google Scholar
• Meregaglia M, Ferrara L, Melegaro A, et al. Parent "cocoon" immunization to prevent pertussis-related hospitalization in infants: the case of Piemonte in Italy. Vaccine 2013;31:1135-7
   PubMed Web of Science ®Google Scholar
• UK Department of Health. Pregnant women to be offered whooping cough vaccination. 2012. Available from: http://www.dh.gov.uk/health/2012/09/whooping-cough/ [Last accessed on 19 August 2014]
   Google Scholar
• Donovan H, Bedford H. Immunisation: changes in the UK for children and young people. Nurs Child Young People 2013;25:16-20
   PubMedGoogle Scholar
• Bundesamt für Gesundheit. Anpassung der Impfempfehlung gegen Pertussis: für Jugendliche, Säuglinge in Betreuungseinrichtungen und schwangere Frauen. BAG Bulletin 9/2013. Available from: http://www.bag.admin.ch/dokumentation/publikationen/01435/13591/index.html?lang=de [Last accessed on 19 August 2014]
   Google Scholar
• Ministerio de Salud de la Nación. Available from: www.msal.gov.ar/prensa/index.php/noticias/noticias-de-la-semana/494-tosconvulsa-ministerio-de-salud-de-lanacion-insta-a-la-vacunacion-de-embarazadas-ninos-y-adolescentes [Last accessed on 19 August 2014]
   Google Scholar
• National Advisory Committee on Immunization. Update on pertussis vaccination in pregnancy. Ottawa, Public Health Agency of Canada; 2014. Available from: http://www.phac-aspc.gc.ca/naci-ccni/acs-dcc/2014/pvip-vcpg_0214-eng.php
   Google Scholar
• Warshawsky B. NACI update on pertussis vaccination in pregnancy. Can Fam Physician 2014;60:521
   PubMed Web of Science ®Google Scholar
• Rasmussen SA, Watson AK, Kennedy ED, et al. Vaccines and pregnancy: past, present, and future. Semin Fetal Neonatal Med 2014;19:161-9
   PubMed Web of Science ®Google Scholar
• Healy CM. Vaccines in pregnant women and research initiatives. Clin Obstet Gynecol 2012;55:474-86
   PubMed Web of Science ®Google Scholar
• van den Berg JP, Westerbeek EAM, van der Klis FRM, et al. Transplacental transport of IgG antibodies to preterm infants: a review of the literature. Early Hum Dev 2011;87:67-72
   PubMed Web of Science ®Google Scholar
• Shakib JH, Ralston S, Raissy HH, et al. Pertussis antibodies in postpartum women and their newborns. J Perinatol 2010;30:93-7
   PubMed Web of Science ®Google Scholar
• Gall SA, Myers J, Pichichero M. Maternal immunization with tetanus-diphtheria-pertussis vaccine: effect on maternal and neonatal serum antibody levels. Am J Obstet Gynecol 2011;334:e1-5
   Google Scholar
• Healy CM, Rench MA, Baker CJ. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants. Clin Infect Dis 2013;56:539-44
   PubMed Web of Science ®Google Scholar
• Leuridan E, Hens N, Peeters N, et al. Effect of a prepregnancy pertussis booster dose on maternal antibody titers in young infants. Pediatr Infect Dis J 2011;30:608-10
   PubMedGoogle Scholar
• Leuridan E, Hoang TT, Dang DA, et al. Pertussis vaccination and pregnancy. Clin Infect Dis 2013;57:471-2
   PubMed Web of Science ®Google Scholar
• Munoz FM. Maternal immunization: an update for pediatricians. Pediatr Ann 2013;42:153-8
   PubMed Web of Science ®Google Scholar
• Munoz FM, Bond NH, Maccato M, et al. Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA 2014;311:1760-9
   PubMed Web of Science ®Google Scholar
• Hardy-Fairbanks AJ, Pan SJ, Decker MD, et al. Immune responses in infants whose mothers received Tdap vaccine during pregnancy. Pediatr Infect Dis J 2013;32:1257-60
   PubMed Web of Science ®Google Scholar
• Quinello C, Quintilio W, Carneiro-Sampaio M, et al. Passive acquisition of protective antibodies reactive with Bordetella pertussis in newborns via placental transfer and breast-feeding. Scand J Immunol 2010;72:66-73
   PubMed Web of Science ®Google Scholar
• van den Berg JP, Westerbeek EA, Berbers GA, et al. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 2010;29:801-5
   PubMed Web of Science ®Google Scholar
• Smallenburg LC, van Welie NA, Elvers LH, et al. Decline of IgG pertussis toxin measured in umbilical cord blood, and neonatal and early infant serum. Eur J Clin Microbiol Infect Dis 2014;33:1541-5
   PubMed Web of Science ®Google Scholar
• Warfel JM, Papin JF, Wolf RF, et al. Maternal and neonatal vaccination protects newborn baboons from pertussis infection. J Infect Dis 2014;210:604-10
   PubMed Web of Science ®Google Scholar
• Heininger U, Riffelmann M, Bär G, et al. The protective role of maternally derived antibodies against Bordetella pertussis in young infants. Pediatr Infect Dis J 2013;32:695-8
   PubMed Web of Science ®Google Scholar
• Nooitgedagt JE, de Greeff SC, Elvers BH, et al. Seroprevalence of Bordetella pertussis infection during pregnancy measured by IgG antibodiesagainst pertussis toxin. Clin Infect Dis 2009;49:1086-9
   PubMed Web of Science ®Google Scholar
• Plans P, Alvarez E, de Ory F, et al. Prevalence of Antibody to Bordetella pertussis in Neonates and Prevalence of Recent Pertussis Infection in Pregnant Women in Catalonia (Spain) in 2003 and 2013. Pediatr Infect Dis J 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Polewicz M, Graciaa A, Buchanana R, et al. Influence of maternal antibodies on active pertussis toxoid immunization of neonatal mice and piglets. Vaccine 2011;29:7718-26
   PubMed Web of Science ®Google Scholar
• Halperin S. Pertussis maternal immunisation study. Available from: http://clinicaltrials.gov/show/nct00553228 [Last accessed on 19 August 2014]
   Google Scholar
• Zheteyeva YA, Moro PL, Tepper NK, et al. Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol 2012;207:59.e1-7
   Web of Science ®Google Scholar
• National Health Service. Whooping cough vaccination in pregnancy. Available from: http://www.nhs.uk/conditions/pregnancy-and-baby/Pages/Whooping-cough-vaccination-pregnant.aspx [Last accessed on 19 August 2014]
   Google Scholar
• Donegan K, King B, Bryan P. Safety of pertussis vaccination in pregnant women in UK: observational study. BMJ 2014;349:g4219
   PubMed Web of Science ®Google Scholar
• Shakib JH, Korgenski K, Sheng X, et al. Tetanus, diphtheria, acellular pertussis vaccine during pregnancy: pregnancy and infant health outcomes. J Pediatr 2013;163:1422-6
   PubMed Web of Science ®Google Scholar
• Gupta S, Campbell H, Dolan GP, et al. Vaccination in pregnancy to prevent pertussis in early infancy. Cochrane Database Syst Rev 2014(1)):CD010923
   Google Scholar
• Public Health England and Department of Health. Continuation of whooping cough vaccination programme in pregnancy advised. 2014. Available from: https://www.gov.uk/government/news/continuation-of-whooping-cough-vaccination-programme-in-pregnancy-advised [Last accessed on 19 August 2014]
   Google Scholar
• Amirthalingam G, Andrews N, Campbell H, et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet 2014. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Kharbanda EO, Parker ED, Nordin JD, et al. Influenza and pertussis vaccination coverage among privately insured women of reproductive age. Matern Child Health J 2013;17:1631-7
   PubMed Web of Science ®Google Scholar
• Goldfarb IT, Little S, Brown J, et al. Use of the combined tetanus-diphtheria and pertussis vaccine during pregnancy. Am J Obstet Gynecol 2014;211(3):299.e1-5
   Web of Science ®Google Scholar
• Terranella A, Asay GR, Messonnier ML, et al. Pregnancy dose Tdap and postpartum cocooning to prevent infant pertussis: a decision analysis. Pediatrics 2013;131:e1748-56
   PubMed Web of Science ®Google Scholar
• Belloni C, De Silvestri A, Tinelli C, et al. Immunogenicity of a three-component acellular pertussis vaccine administered at birth. Pediatrics 2003;111:1042-5
   PubMed Web of Science ®Google Scholar
• Wood N, McIntyre P, Marshall H, et al. Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age. Pediatr Infect Dis J 2010;29:209-15
   PubMed Web of Science ®Google Scholar
• Knuf M, Schmitt HJ, Wolter J, et al. Neonatal vaccination with an acellular pertussis vaccine accelerates the acquisition of pertussis antibodies in infants. J Pediatr 2008;152:655-60
   PubMed Web of Science ®Google Scholar
• White OJ, Rowe J, Richmond P, et al. Th2-polarisation of cellular immune memory to neonatal pertussis vaccination. Vaccine 2010;28:2648-52
   PubMed Web of Science ®Google Scholar
• Feunou PF, Kammoun H, Debrie AS, et al. Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine 2010;28:7047-53
   PubMed Web of Science ®Google Scholar
• Nascimento IP, Dias WO, Quintilio W, et al. Neonatal immunization with a single dose of recombinant BCG expressing subunit S1 from pertussis toxin induces complete protection against Bordetella pertussis intracerebral challenge. Microbes Infect 2008;10:198-202
   PubMed Web of Science ®Google Scholar
• Nascimento IP, Dias WO, Quintilio W, et al. Construction of an unmarked recombinant BCG expressing a pertussis antigen by auxotrophic complementation: protection against Bordetella pertussis challenge in neonates. Vaccine 2009;27:7346-51
   PubMed Web of Science ®Google Scholar
• Mielcarek N, Debrie AS, Raze D, et al. Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2006;2:e65
   PubMed Web of Science ®Google Scholar
• Skerry CM, Cassidy JP, English K, et al. A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout. Clin Vaccine Immunol 2009;16:1344-51
   PubMedGoogle Scholar
• Fedele G, Bianco M, Debrie AS, et al. Attenuated Bordetella pertussis vaccine candidate BPZE1 promotes human dendritic cell CCL21-induced migration and drives a Th1/Th17 response. J Immunol 2011;186(9):5388-96
   PubMed Web of Science ®Google Scholar
• Institut National de la Santé Et de la Recherche Médicale, France. First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine. Available from: http://clinicaltrials.gov/show/NCT01188512 [Last accessed on 19 August 2014]
   Google Scholar
• Polewicz M, Gracia A, Garlapati S, et al. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Vaccine 2013;31:3148-55
   PubMed Web of Science ®Google Scholar